PP

Progress Pharma

BE0536.258.560

Gross margin
€ -5K ↓ 108% 2025 Total € -394K
Profit
€ -5K ↓ 88% 2025 Total € -413K
EBITDA
€ -5K ↓ 89% 2025 Total € -400K
EBIT
€ -5K ↓ 89% 2025 Total € -412K
Net profit
€ -5K ↓ 88% 2025 Total € -413K
Assets
€ 50K ↓ 47% 2025
Equity
€ 47K ↓ 49% 2025
Debt
€ 3K ↑ 95% 2025
Cash
€ 18K ↓ 71% 2025
Cashflow
€ -5K ↓ 88% 2025 Total € -400K
Working capital
€ 15K ↓ 75% 2025
Current ratio
6.47 ↓ 85% 2025
Quick ratio
6.47 ↓ 85% 2025
Working capital ratio
6.47 ↓ 85% 2025
Debt
€ 3K ↑ 95% 2025
Short-term debt
€ 3K ↑ 95% 2025
Debt / EBITDA
0.82 2015
Solvability
94.4% ↓ 4.1 pt 2025
Gross profitability
-11.6% ↓ 8.5 pt 2025
Net profitability
-11.6% ↓ 8.5 pt 2025
Return On Assets (ROA)
-10.97 ↓ 253% 2025
Return On Equity (ROE)
-11.62 ↓ 269% 2025